Risk factors

ENDRA Life Sciences (NDRA) risk factors

Item 1A of every ENDRA Life Sciences Inc. 10-K on file, and what changed from one year to the next.

  • FY2025 10-K risk factors

    64 risks. TAEUS commercialization depends on regulatory clearances, market adoption, reimbursement, and building sales and distribution capabilities.

    Filed Mar 31, 2026